![Philip Donenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philip Donenberg
Direktor/Vorstandsmitglied bei
TAYSHA GENE THERAPIES, INC.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Philip B. Donenberg is currently Director at Sensei Biotherapeutics, Inc. since 2026, Independent Director at Taysha Gene Therapies, Inc. since 2020, and Independent Director at Tectonic Therapeutic, Inc. since 2024.
Former roles include Independent Director at AVROBIO, Inc., Controller at Unimed Pharmaceuticals LLC from 1995 to 1998, Chief Financial Officer & Senior Vice President at Assertio Therapeutics, Inc. in 2018, Chief Financial Officer, Secretary & Senior VP at ANI Pharmaceuticals, Inc. from 2011 to 2013, Controller at Applied NeuroSolutions, Inc., Controller at Molecular Geriatrics Corp from 1993 to 1994, Controller at Xtramedics, Inc., Controller at Gynex Pharmaceuticals, Inc., Chief Financial Officer at 7wire Ventures LLC from 2013 to 2014, Chief Financial Officer & Secretary at RestorGenex Corp.
from 2015 to 2016, Chief Financial Officer at Diffusion Pharmaceuticals, Inc., Chief Financial Officer & Senior Vice President at Jaguar Gene Therapy LLC from 2020 to 2023, and Chief Financial Officer & Senior Vice President at Novartis Gene Therapies, Inc. from 2017 to 2018.
Education includes undergraduate studies at the University of Illinois At Urbana–Champaign.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.06.2026 | 241’289 ( 0.09% ) | 1 Mio $ | 31.05.2026 | |
0% | 09.06.2026 | 166 ( 0% ) | 5 173 $ | 31.05.2026 |
| 10.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Philip Donenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Direktor/Vorstandsmitglied | 31.08.2020 |
| SENSEI BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 13.02.2026 |
Ehemalige bekannte Positionen von Philip Donenberg
| Unternehmen | Position | Ende |
|---|---|---|
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Finanzdirektor/CFO | 01.03.2023 |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Finanzdirektor/CFO | 30.11.2018 |
| AVEXIS INC | Finanzdirektor/CFO | 01.07.2018 |
| DIFFUSION PHARMA | Finanzdirektor/CFO | 01.09.2016 |
RestorGenex Corp.
 RestorGenex Corp. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and sells medicines | Finanzdirektor/CFO | 08.01.2016 |
Ausbildung von Philip Donenberg
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Unimed Pharmaceuticals LLC
 Unimed Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
ANI Pharmaceuticals, Inc.
 ANI Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the developing, manufacturing and marketing of generic pharmaceutical products | Health Technology |
Applied NeuroSolutions, Inc.
 Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Researches and develops pharmaceuticals | Health Technology |
Molecular Geriatrics Corp
 Molecular Geriatrics Corp Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products for the treatment and detection of Alzheimers and cancer | Commercial Services |
Xtramedics, Inc.
 Xtramedics, Inc. Household/Personal CareConsumer Non-Durables Feminine hygiene products | Consumer Non-Durables |
Gynex Pharmaceuticals, Inc.
 Gynex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
7wire Ventures LLC
 7wire Ventures LLC Investment ManagersFinance 7wire Ventures invests in companies located in the United States. The firm targets companies operating in the field of the healthcare sector. It provides financing for early and later stage capital requirements. | Finance |
RestorGenex Corp.
RestorGenex Corp. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and sells medicines | Health Technology |
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage gene therapy company | Health Technology |
Diffusion Pharmaceuticals, Inc.
 Diffusion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapies | Health Technology |
AVROBIO, Inc.
 AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Jaguar Gene Therapy LLC
Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Provides gene therapy for patients | Health Services |
